January, 2026
January 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Talha Badar and Team: New VTE Risk Prediction Model Validated for Asparaginase-Treated ALL
Nov 6, 2025, 05:10

Talha Badar and Team: New VTE Risk Prediction Model Validated for Asparaginase-Treated ALL

Talha Badar, Hematologist-Oncologist at Mayo Clinic Comprehensive Cancer Center, posted on X:

”Derivation and External Validation of a Venous Thromboembolism Risk Prediction Model in Asparaginase-Treated ALL

Happy to contribute in this effort by ALL NCTN:

High VTE rates persist in asparaginase-treated ALL despite prophylaxis.

Externally validated VTE risk model using D-dimer and hemoglobin at diagnosis.”

Read the full article here.

Title: Derivation and External Validation of a Venous Thromboembolism Risk Prediction Model in Asparaginase-Treated ALL

Authors: Daniela R. Anderson, Radhika Gangaraju, Wafik G. Sedhom, Eva N. Hamulyák, Tzu-Fei Wang, Kristen M O’Dwyer, Brian J. Carney, Chandrasekar Muthiah, Michaela Liedtke, Talha Badar, Shai Shimony, Renana Robinson, Kristen Sanfilippo, Andriy Derkach, Shira Naomi Dinner, Bart J. Biemond, David Nemirovsky, Leah A. Goldberg, Anjani D. Kapadia, Hannah Levavi, Michal Bar-Natan, Grace Van Hyfte, Karan Bansal, Marc Carrier, Jill Fulcher, Anke M. Gerrits, Mark R. Litzow, Selina M Luger, Guru Subramanian Guru Murthy, Marlise R. Luskin, Ofir Wolach, William Shomali, Jeffrey I. Zwicker, Wendy A Stock, Avi Leader

Talha Badar and Team: New VTE Risk Prediction Model Validated for Asparaginase-Treated ALL Venous Thromboembolism

Stay updated with Hemostasis Today.